# Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

> **NCT00646152** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 57 (actual)

## Conditions studied

- Influenza
- Severe Acute Respiratory Distress Syndrome
- Smallpox
- Ebola
- Unknown Respiratory Viruses

## Interventions

- **DRUG:** Poly-ICLC

## Key facts

- **NCT ID:** NCT00646152
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-24
- **Primary completion:** 2009-12-16
- **Final completion:** 2009-12-16
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646152, "Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00646152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*